Werewolf Therapeutics Inc

NASDAQ:HOWL   3:59:50 PM EDT
4.51
+0.55 (+13.89%)
Earnings Announcements

Werewolf Therapeutics Reports Fourth Quarter 2021 And Full Year 2021 Financial Results

Published: 03/24/2022 11:23 GMT
Werewolf Therapeutics Inc (HOWL) - Werewolf Therapeutics Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Highlights.
Werewolf Therapeutics - Expects Existing Cash, Equivalents to Enable Funding of Operating Expenses and Capex Needs Through at Least Q2 of 2023.
Qtrly Loss per Share $0.66.
Q4 Earnings per Share View $-0.53 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.75 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.